Regulatory Framework of Clinical Trials in BRIC Nations
Long heralded by global sponsors as cost-effective alternatives to western markets, the BRIC nations – Brazil, Russia, India, and China – are experiencing declines in...
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.